Rouan Sarah Kathryn (CIK 1761366) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-05). Recent activity: Buy VKTX (3,150 shares), Buy VKTX (1,240 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-05 | Viking Therapeutics, Inc. (VKTX) | Director | Buy | 3,150 | $0 |
| 2025-04-08 | Viking Therapeutics, Inc. (VKTX) | Director | Buy | 1,240 | $29,946 |
来源：SEC Form 4 申报文件 · 截至 2026-01-05